Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: UK Trade Gap Widens; German Industrial Production Stalls

Fri, 06th Feb 2015 11:17

LONDON (Alliance News) - The following is a summary of top news stories Friday.
----------
COMPANIES
----------
Shire was accused of tax avoidance by the UK's Public Accounts Committee as part of a damning report issued by the committee into the role played by Big Four accountancy PricewaterhouseCoopers in helping its clients avoid paying tax. The PAC said the evidence submitted to its investigation into PwC failed to convince it that the schemes the accountancy has promoted to its clients constituted anything other than the promotion of tax avoidance "on an industrial scale". It said the UK government and tax collector HM Revenue & Customs need to take a more active role in regulating the tax industry and said HMRC needs to do more to challenge the nature of the advice given by accountancies to their clients.
----------
Capita said it has been approved to join the lead provider framework for NHS England's commissioning support services. Capita said clinical commissioning groups in the UK will be required to re-procure many support services by April 2016 in order to comply with European procurement law. The FTSE 100-listed outsourcing company said NHS England anticipates this will result in GBP3 billion to GBP5 billion in services being procured through the framework.
----------
GlaxoSmithKline said it has received positive results from the phase 3 study investigating the combination of the dabrafenib and trametinib drugs. Glaxo said the overall survival rates from the combination of the drugs showed a statistically significant fall in the risk of death from combining the pair in comparison to dabrafenib monotherapy in patients with BRAF V600E/K mutation-positive metastatic melanoma.
----------
The Irish government is not yet convinced of the merits of International Consolidated Airlines Group's takeover bid for Aer Lingus Group, the Irish Independent reported, quoting Transport Minister Paschal Donohoe. Donohoe said the interdepartmental group which is advising on the offer has held a second meeting with IAG but said the discussions failed to allay concerns over a potential sale of the carrier. "IAG have laid out the circumstances in which they would be prepared to make a formal bid. However, we as a shareholder remain to be convinced regarding the merits of what they're putting forward," Donohoe told the Irish Independent.
----------
Poundland Group shares pushed higher after the retailer snapped up rival 99p Stores in a GBP55 million cash and shares deal. Poundland said it will pay GBP47.5 million in cash for its fellow high-street discounter, along with a further GBP7.5 million in shares.It said the equity placing will happen at or immediately prior to the closing of the deal and an increase in Poundland's revolving credit facilities. The deal includes 99p Stores' network of 251 stores, which trade at 99p Stores and Family Bargains, along with its warehouse and distribution centre. Poundland said. In the year to February 1, 2014, 99p Stores reported underlying earnings before interest, taxation, depreciation and amortisation of GBP6.1 million on sales of GBP370.4 million, it said.
----------
Shares in Tate & Lyle plummeted after the company said it expects its full year profit to fall below its guidance on the back of continuing problems in its bulk ingredients business and said it will take action to try and improve its operation and supply chain following prolonged issues. The sugar company said it expects its profit for the year to the end of March to come in below the guidance it gave in September of GBP230 million to GBP245 million, owing to the weak performance in the bulk ingredients business in the third quarter and expectations this will not improve in the final quarter. The bulk ingredients performance will offset the results from its specialty food ingredients arm, which it expects to be in line with expectations.
----------
The UK Environment Agency said it has granted environmental permits to Cuadrilla Resources which will allow the company to carry out its proposed shale gas exploration on the Roseacre Wood site if it can convince the Lancashire County Council to agree. The permits awarded to Cuadrilla, which is spearheading onshore fracking in the UK, covers groundwater, surface water and air quality and ensures the safe storage, management and disposal of waste.
----------
DFS Furniture said it plans to list on main market of the London Stock Exchange in an initial public offering aimed at raising GBP105 million so it can pay down existing debt and lower the costs of financing in the future. DFS, which specialises in sofas, said it also will put existing cash and the GBP200 million proceeds from a new senior facilities agreement to repay the outstanding debt from its existing bond financing. In addition to the company's own fundraising with new shares, a partial sale of existing shares held by an entity indirectly controlled by funds managed by private equity firm Advent International Corp and members of the company's management team also will be included. Advent owns about 85% of DFS, with the remainder belonging to company directors and management.
----------
MARKETS
----------
London's leading stock indices are trading lower mid-morning, as investors continue to focus on Greek debt troubles while awaiting the US nonfarm payroll count at 1330 GMT.
----------
FTSE 100: down 0.3% at 6,849.23
FTSE 250: down 0.2% at 16,658.04
AIM ALL-SHARE: up 0.3% at 699.88
----------
The pound is flat against the dollar after data showed the UK trade deficit widening in December.
----------
GBP-USD: flat at USD1.5328
EUR-USD: down at USD1.1438

GOLD: down at USD1264.04 per ounce
OIL (Brent): up at USD58.47 a barrel

(changes since end of previous GMT day)
----------
ECONOMICS AND GENERAL
----------
The UK visible trade deficit widened in December, as imports surged, the Office for National Statistics said. The visible trade gap rose to GBP10.2 billion in December from GBP9.28 billion in November. Economists expected a GBP9.1 billion deficit. The deficit on trade in goods with EU nations narrowed to GBP6.4 billion from GBP6.5 billion in the previous month while that with non-EU nations increased to GBP3.8 billion from GBP2.8 billion, more than the GBP3 billion deficit expected by economists.
----------
UK firms hired staff at a slower rate in January despite growth in demand for staff, results of a survey by the Recruitment and Employment Confederation, or REC, and KPMG showed. Permanent staff appointments rose at a slowest rate in twenty months in January. Temporary staff appointments increased at the weakest rate since October. However, overall job vacancies grew at the fastest rate in three months as growth in permanent and temporary vacancies quickened. Average starting salaries for people placed in permanent positions increased at the strongest rate in four months. Pay for temporary staff also climbed, though at the weakest pace in nine months.
----------
Germany's industrial production growth remained stable in December, defying expectations for a faster rate of increase. Industrial output grew 0.1% in December from a month ago, Destatis reported. Production was forecast to rise 0.4% after expanding by a revised 0.1% in November. Annually, production fell 0.7% in December, more than the 0.3% decline expected by economists.
----------
German Chancellor Angela Merkel and French President Francois Hollande joined top US diplomat John Kerry in Kiev as they mounted a fresh diplomatic push to halt the escalating violence in eastern Ukraine. Merkel and Hollande met with Ukrainian President Petro Poroshenko on Thursday and travel to Moscow for a meeting Friday with Russian President Vladimir Putin. Hollande said he and Merkel will present "a new proposal for a comprehensive settlement based on the territorial integrity of Ukraine." Following a meeting between Poroshenko and Kerry earlier in the day, the US secretary of state laid out so-called confidence-building measures that should be taken by Moscow as a first step towards ending the conflict.
----------
The Reserve Bank of Australia lowered its GDP growth and inflation forecasts after announcing its decision to cut rates earlier in the week, painting a gloomy picture of the economy. Growth overall is now forecast to remain at a below-trend pace somewhat longer than had earlier been expected, the RBA said in its quarterly Monetary Policy Statement. The bank said that the economy is expected to grow at a pace of 2.25% to 3.25% through December 2015 and 3% to 4% in the following year. This was less than the previous forecast for 2.5% to 3.5% GDP growth in 2015 and 2.75% to 4.25% in 2016.
----------
Meanwhile, Australian Prime Minister Tony Abbott is to face a first major test to his leadership next week after one of his own party members said Friday he would bring a motion against him at a party meeting. The motion would be brought at the next Liberal party meeting on Tuesday.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.